Fundraising FoxOCV Partners — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)inMatt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsAvenir Growth CapitalB3 HoldingKleinmuntz AssociatesOctave Ventures LlcOMX VenturesShumway Capital+2 more
Hemi is a specialized private clinic for diagnosing and treating headache disorders — including migraine, tension headache, cluster headache, concussion, and whiplash-related symptoms — in both children and adults.
Digital HealthHealthtechWellness & FitnessFrederiksberg, DK
Co-investorsAlliance VCAlliance VentureCrowberry CapitalSondo CapitalAccelRibbit Capital
Subscription-based mobile app helping small business owners win jobs, track payments, and manage client payment options.
Co-investorsAccelRibbit Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.